Literature DB >> 10639602

Serum total cholesterol and triglycerides levels in patients with lung cancer.

K Siemianowicz1, J Gminski, M Stajszczyk, W Wojakowski, M Goss, M Machalski, A Telega, K Brulinski, H Magiera-Molendowska.   

Abstract

Epidemiological studies indicate that low serum total cholesterol level may increase the risk of death due to cancer, mainly lung cancer. The aim of our study was to evaluate serum levels of total cholesterol (TC) and triglycerides (TG) in patients with squamous cell and small cell lung cancer and their dependence on the histological type and the clinical stage of the neoplasm. Lung cancer patients (n=135) and healthy controls (n=39) entered the study. All lung cancer patients had higher rate of hypocholesterolemia and lower TC and TG levels than the control group. TC concentration was lower in lung cancer patients and in both histological types in comparison with the control group, TG level was lower only in patients with squamous cell lung cancer. There were no statistically significant differences of TC and TG levels between the histological types, or between the clinical stages of each histological type.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639602     DOI: 10.3892/ijmm.5.2.201

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  21 in total

1.  Preoperative total serum cholesterol as a prognostic factor for survival in patients with resectable non-small-cell lung cancer.

Authors:  Mihael Sok; Janez Ravnik; Maja Ravnik
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

2.  Elevated apolipoprotein A-I levels are associated with favorable prognosis in metastatic nasopharyngeal carcinoma.

Authors:  Rou Jiang; Zhong-Han Yang; Dong-Hua Luo; Ling Guo; Rui Sun; Qiu-Yan Chen; Pei-Yu Huang; Fang Qiu; Xiong Zou; Ka-Jia Cao; Hai-Qiang Mai; Xiang Guo; Chao-Nan Qian; Ming-Huang Hong; Ming-Yuan Chen
Journal:  Med Oncol       Date:  2014-07-15       Impact factor: 3.064

3.  Circulating Lipoproteins: A Trojan Horse Guiding Squalenoylated Drugs to LDL-Accumulating Cancer Cells.

Authors:  Dunja Sobot; Simona Mura; Marie Rouquette; Branko Vukosavljevic; Fanny Cayre; Eric Buchy; Grégory Pieters; Sébastien Garcia-Argote; Maike Windbergs; Didier Desmaële; Patrick Couvreur
Journal:  Mol Ther       Date:  2017-06-09       Impact factor: 11.454

4.  Decreased pretreatment serum cholesterol level is related with poor prognosis in resectable non-small cell lung cancer.

Authors:  Jin-Rui Li; Ye Zhang; Jia-Lian Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  Clerodendron inerme protects cellular integrity during 7,12-dimethylbenz[A]-anthracene induced hamster buccal pouch carcinogenesis.

Authors:  Shanmugam Manoharan; Kannan Kavitha; Subramanian Balakrishnan; Kasinathan Rajalingam
Journal:  Afr J Tradit Complement Altern Med       Date:  2008-01-22

6.  Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: a cross-sectional study.

Authors:  Jinyan Zhao; Yunpeng Zhao; Hao Wang; Xing Gu; Jun Ji; Chunfang Gao
Journal:  Nutr J       Date:  2011-05-15       Impact factor: 3.271

7.  Paraoxonase-1 (PON1) induces metastatic potential and apoptosis escape via its antioxidative function in lung cancer cells.

Authors:  Mark Borris D Aldonza; Yeon Sung Son; Hye-Jin Sung; Jung Mo Ahn; Young-Jin Choi; Yong-In Kim; Sukki Cho; Je-Yoel Cho
Journal:  Oncotarget       Date:  2017-06-27

8.  Serum Metabolite Profiles in Participants of Lung Cancer Screening Study; Comparison of Two Independent Cohorts.

Authors:  Piotr Widłak; Karol Jelonek; Agata Kurczyk; Joanna Żyła; Magdalena Sitkiewicz; Edoardo Bottoni; Giulia Veronesi; Joanna Polańska; Witold Rzyman
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

Review 9.  Influence of liver cancer on lipid and lipoprotein metabolism.

Authors:  Jingting Jiang; Peter Nilsson-Ehle; Ning Xu
Journal:  Lipids Health Dis       Date:  2006-03-03       Impact factor: 3.876

10.  Serum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinoma.

Authors:  Xiao-Lin Luo; Guang-Zheng Zhong; Li-Yang Hu; Jie Chen; Ying Liang; Qiu-Yan Chen; Qing Liu; Hui-Lan Rao; Kai-Lin Chen; Qing-Qing Cai
Journal:  Oncotarget       Date:  2015-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.